SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The New Economy and its Winners -- Ignore unavailable to you. Want to Upgrade?


To: Bill Harmond who wrote (5247)2/1/2001 12:00:11 AM
From: Mark Fowler  Read Replies (4) | Respond to of 57684
 
I'm reading itand i notice Cra has been signing on more here: Celera earlier this month announced several other database-subscription deals, including with the
Max Planck Society for Advancement of Science in Germany, the Karolinska Institute in Sweden,
and the University of Tokyo in Japan....

Bill Here's the lastest price target,
Princeton, New Jersey, Jan. 29 (Bloomberg Data) -- Celera Genomics Group-appler (CRA US)
was reiterated ``buy'' by analyst Todd Nelson at Dain Rauscher Wessels. The target price is $151
per share.